Todd Cozzens

The round was led by Todd Cozzens and had participation from existing investors Khosla Ventures, Founders Fund, Green Innovations, Vesalius Biocapital and Faber.
SWORD Health closes $25 million Series B round to accelerate company growth
By Mallory Hackett | 01:05 pm | January 29, 2021
The round was led by Todd Cozzens and had participation from existing investors Khosla Ventures, Founders Fund, Green Innovations, Vesalius Biocapital and Faber.